A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate

A Brief Review of Low-Dose Rate (LDR) and High-Dose Rate (HDR) Brachytherapy Boost for High-Risk Prostate

For patients with unfavorable or high-risk prostate cancer, dose escalated radiation therapy leads to improved progression free survival but attempts to deliver increased dose by external beam radiation therapy (EBRT) alone can be limited by late toxicities to nearby genitourinary and gastrointestin...

Full description

Bibliographic Details
Main Authors: Benjamin W. Fischer-Valuck, Hiram A. Gay, Sagar Patel, Brian C. Baumann, Jeff M. Michalski
Format: Article
Language:English
Published: Frontiers Media S.A. 2019-12-01
Series:Frontiers in Oncology
Subjects:
HDR
LDR
brachytherapy
boost
high risk prostate
cancer
Online Access:https://www.frontiersin.org/article/10.3389/fonc.2019.01378/full

Internet

https://www.frontiersin.org/article/10.3389/fonc.2019.01378/full

Similar Items